gastrointestinal agents

Preferred Label : gastrointestinal agents;

MeSH definition : Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.;

MeSH synonym : agents, gastrointestinal; drugs, gastrointestinal; gastrointestinal drugs;

MeSH hyponym : gastric agents; Agents, Gastric; Gastric Drugs; Drugs, Gastric;

Related MeSH term : digestants;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D005765;

UMLS CUI

C0017173;

ATC code(s)
- sulfasalazine [ATC Code]
ATC code(s)
- betaine [ATC Code]
- chenodeoxycholic acid [ATC Code]
- cholic acid [ATC Code]
- digestives, incl. enzymes [ATC Code]
- drugs for functional gastrointestinal disorders [ATC Code]
- lactulose, combinations [ATC Code]
- multienzymes (lipase, protease etc.) [ATC Code]
- silicones [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Gastrointestinal drug [ICD-11 Extension code]
- Gastrointestinal drug (product) [Inactive SNOMED CT concept]
- gastrointestinal drug, nos [SNOMED Notion]
False automatic mappings
- Digestants [ICD-10 Sub-category (who)]
Indexing information
- ALX-0600 [MeSH Supplementary Concept]
- AZD2066 [MeSH Supplementary Concept]
- SHR116958 [MeSH Supplementary Concept]
- eluxadoline [MeSH Supplementary Concept]
- gastrosis no. 1 [MeSH Supplementary Concept]
- panchelidon [MeSH Supplementary Concept]
- panzynorm [MeSH Supplementary Concept]
- tegaserod [MeSH Supplementary Concept]
- xiaopi-I [MeSH Supplementary Concept]
Metaterm(s)
- gastroenterology [CISMeF Metaterm]
Record concept(s)
- digestants [MeSH concept]
- gastric agents [MeSH concept]
- gastrointestinal agents [MeSH concept]
See also
- cholecystokinin [MeSH Descriptor]
- epidermal growth factor [MeSH Descriptor]
- gastrins [MeSH Descriptor]
- gastrointestinal hormones [MeSH Descriptor]
- glucagon-like peptides [MeSH Descriptor]
- pentagastrin [MeSH Descriptor]
- sincalide [MeSH Descriptor]
- tetragastrin [MeSH Descriptor]
See also (suggested by CISMeF)
- secretin [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- CDP 571 [MeSH Supplementary Concept]
- DS-3801b [MeSH Supplementary Concept]
- EM 523 [MeSH Supplementary Concept]
- Etanercept [MeSH Descriptor]
- Infliximab [MeSH Descriptor]
- Rifaximin [MeSH Descriptor]
- STNM01 [MeSH Supplementary Concept]
- Z 338 [MeSH Supplementary Concept]
- acemannan [MeSH Supplementary Concept]
- alemcinal [MeSH Supplementary Concept]
- alicaforsen [MeSH Supplementary Concept]
- alosetron [MeSH Supplementary Concept]
- alvimopan [MeSH Supplementary Concept]
- atilmotin [MeSH Supplementary Concept]
- atropine sulfate-diphenoxylate hydrochloride drug combination [MeSH Supplementary Concept]
- balsalazide [MeSH Supplementary Concept]
- betazole [MeSH Descriptor]
- bile acids and salts [MeSH Descriptor]
- catumaxomab [MeSH Supplementary Concept]
- cholic acids [MeSH Descriptor]
- cholylsarcosine [MeSH Supplementary Concept]
- cyproheptadine [MeSH Descriptor]
- eluxadoline [MeSH Supplementary Concept]
- erythromycin [MeSH Descriptor]
- erythromycin estolate [MeSH Descriptor]
- erythromycin ethylsuccinate [MeSH Descriptor]
- erythromycin lactobionate [MeSH Supplementary Concept]
- erythromycin stearate [MeSH Supplementary Concept]
- etrolizumab [MeSH Supplementary Concept]
- fexuprazan [MeSH Supplementary Concept]
- gastric inhibitory polypeptide [MeSH Descriptor]
- gastrin-releasing peptide [MeSH Descriptor]
- glucagon [MeSH Descriptor]
- honokiol [MeSH Supplementary Concept]
- lactulose [MeSH Descriptor]
- lesogaberan [MeSH Supplementary Concept]
- mosapride [MeSH Supplementary Concept]
- motilin [MeSH Descriptor]
- octreotide [MeSH Descriptor]
- octylonium [MeSH Supplementary Concept]
- olsalazine [MeSH Supplementary Concept]
- pancreatic polypeptide [MeSH Descriptor]
- pancreatin [MeSH Descriptor]
- pancrelipase [MeSH Descriptor]
- pepsin A [MeSH Descriptor]
- ridogrel [MeSH Supplementary Concept]
- secretin [MeSH Descriptor]
- sulfasalazine [MeSH Descriptor]
- teduglutide [MeSH Supplementary Concept]
- trimebutine [MeSH Descriptor]
- vasoactive intestinal peptide [MeSH Descriptor]
- vedolizumab [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Gastrointestinal agent (substance) [SNOMED CT concept]
- Gastrointestinal drug [ICD-11 Extension code]
- Gastrointestinal drug (product) [Inactive SNOMED CT concept]
- Gastrointestinal drugs [LOINC hierarchical part]
- gastrointestinal drug, nos [SNOMED Notion]
Validated automatic mappings to BTNT
- Digestants [Bloc CIM-11]
Validated automatic mappings to NTBT
- Agents primarily affecting the gastrointestinal system [Bloc CIM-11]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients